医疗补助受益者中阿片类使用障碍的照护级联
该重复横断面研究利用2018—2023年医疗补助索赔数据,测量年份为2019至2023年,纳入47个州和哥伦比亚特区18至64岁非双重资格医疗补助受益者,共126 430 422个受益者-年观察。主要结局为OUD诊断、接受MOUD、MOUD持续至少180天以及OUD相关住院或急诊就诊的百分比。结果显示OUD诊断率从4.2%降至3.6%(34个州下降),接受MOUD者从60.0%升至69.1%(45个州上升),MOUD持续至少180天者从62.6%降至57.6%(29个州下降),OUD相关住院或急诊就诊从10.9%降至10.6%(31个州上升)。作者认为MOUD使用增加可能有助于减少过量死亡,但需更多研究。
要点
- 2019至2023年,医疗补助受益者中OUD诊断率从4.2%降至3.6%,在34个州下降。
- 所有OUD受益者中接受MOUD的百分比从60.0%升至69.1%,在45个州上升。
- 接受MOUD且持续至少180天的百分比从62.6%降至57.6%,在29个州下降。
- OUD相关住院或急诊就诊百分比从10.9%降至10.6%,但在31个州上升。
- 作者认为MOUD使用增加可能有助于减少过量死亡,但需更多研究。
适用人群与场景
- 47个州和哥伦比亚特区18至64岁非双重资格医疗补助受益者,2019至2023测量年份。
- 数据来源为2018—2023年医疗补助索赔数据。
研究设计与关键结果
- 重复横断面研究,126 430 422个受益者-年观察,年龄35-64岁占47.7%-52.3%,女性占59.5%-61.2%。
- OUD诊断百分比从2019年4.2%降至2023年3.6%,在34个州下降。
- 所有OUD受益者中接受MOUD的百分比从60.0%升至69.1%,在45个州上升。
- MOUD持续至少180天的百分比从62.6%降至57.6%,在29个州下降。
- OUD相关住院或急诊就诊百分比从10.9%降至10.6%,但在31个州上升。
证据类型、等级与局限
- 研究类型:重复横断面研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为MOUD使用增加可能有助于减少过量死亡,但需更多研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Opioid use disorder (OUD) is a major cause of death and disability among Medicaid beneficiaries. Understanding progress on engaging Medicaid beneficiaries in effective treatment is vital for reducing burden.
OBJECTIVE: To examine changes over time and state variation in rates of OUD diagnosis, receipt of medications for OUD (MOUD), MOUD continuity, and OUD-related hospitalization or emergency department (ED) visits among Medicaid beneficiaries.
DESIGN, SETTING, AND PARTICIPANTS: This repeated cross-sectional study used 2018-2023 Medicaid claims data for measurement years 2019 to 2023. The study included non-dual eligible Medicaid beneficiaries aged 18 to 64 years residing in 47 states and the District of Columbia. The data analyses were performed between July 1 and December 11, 2025.
EXPOSURE: Medicaid coverage.
MAIN OUTCOMES AND MEASURES: The main outcome was the percentage of Medicaid beneficiaries with (1) an OUD diagnosis, (2) MOUD, (3) MOUD continuity for at least 180 days, and (4) OUD-related hospitalization or emergency department visit.
RESULTS: Among 126 430 422 Medicaid beneficiary-year observations (aged 35-64 years range, 47.7%-52.3%; female range, 59.5%-61.2%), the percentage diagnosed with OUD declined from 4.2% in measurement year 2019 to 3.6% in measurement year 2023 and declined in 34 states. The percentage of all Medicaid beneficiaries with OUD who received MOUD increased from 60.0% to 69.1% and increased in 45 states. The percentage of Medicaid beneficiaries who continued MOUD for at least 180 days decreased from 62.6% to 57.6% and decreased in 29 states. The percentage of beneficiaries with OUD who had an OUD-related hospitalization or ED visit decreased from 10.9% to 10.6% but increased in 31 states.
CONCLUSIONS AND RELEVANCE: This cross-sectional study found a substantial increase in the percentage of individuals with OUD who received MOUD among almost all states. The increase in MOUD use may have contributed to reductions in overdose deaths, but more research is needed.
参考来源
- Lu TT, Dowd WN, Mark TL, et al. Cascade of Care for Opioid Use Disorder Among Medicaid Beneficiaries. JAMA Netw Open. 2026. PMID: 42018324. doi:10.1001/jamanetworkopen.2026.7439
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。